VANCOUVER, BC -- (Marketwired) -- Phyton Biotech, the pioneer in plant cell fermentation (PCF®) technology with the world's largest capacity for paclitaxel and docetaxel API via PCF, has launched a new website: www.phytonbiotech.com.
The new website maintains Phyton's commitment to being the best commercial supplier of paclitaxel and docetaxel API in the world and also emphasizes Phyton's increased focus on Development Services for plant-derived actives via PCF and for complex small molecules.
With GMP development and manufacturing facilities near Hamburg and Vancouver, Phyton was the first company to develop and commercially supply paclitaxel starting material via PCF for Bristol-Myers Squibb Taxol® oncology product. With this track record and its substantial expertise, Phyton has duplicated this success in developing new plant-derived actives for its customers via PCF. Phyton is uniquely positioned to develop and to scale up new actives using its technology for not only the pharmaceutical industry, but for other the food ingredient, cosmetic, and agricultural industries as well. The company has also established a platform for artificial expression of biosimilars via its patented PCF technology. In addition, Phyton's expertise extends into synthesis and purification of taxanes and other complex small molecules. Its world-class scientists have often succeeded where others have failed in the development of new API's.
Anyone seeking more information on Phyton's enhanced Development Services is welcome to visit us at this year's CPhI Worldwide event, October 7th through 9th, in Paris, stand 6G99.
Phyton Biotech is a global supplier of high quality paclitaxel and docetaxel API. The company has development and manufacturing facilities near Hamburg, Germany and Vancouver, Canada. The largest producer of paclitaxel and docetaxel in the world via PCF, Phyton has been inspected by EDQM, EMA, FDA, KFDA, and TGA. Phyton also offers development services to its customers for plant-derived actives via PCF and for complex, small molecules.
For further information, contact:
604-777-2340 x 225